Application 204592
- Type
- NDA
- Sponsor
- ZYLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZORVOLEX | DICLOFENAC | CAPSULE;ORAL | 18MG | Yes | No |
| 002 | ZORVOLEX | DICLOFENAC | CAPSULE;ORAL | 35MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42211-203 | Zorvolex | diclofenac | Iroko Pharmaceuticals LLC | NDA | Current |
| 42211-203 | Zorvolex | diclofenac | Iroko Pharmaceuticals LLC | NDA | Current |
| 42211-204 | Zorvolex | diclofenac | Iroko Pharmaceuticals LLC | NDA | Current |
| 42211-204 | Zorvolex | diclofenac | Iroko Pharmaceuticals LLC | NDA | Current |
| 69344-203 | Zorvolex | diclofenac | Zyla Life Sciences US Inc. | NDA | Current |
| 69344-203 | Zorvolex | diclofenac | Egalet US Inc. | NDA | Current |
| 69344-203 | Zorvolex | diclofenac | Zyla Life Sciences US Inc. | NDA | Current |
| 69344-204 | Zorvolex | diclofenac | Zyla Life Sciences US Inc. | NDA | Current |
| 69344-204 | Zorvolex | diclofenac | Egalet US Inc. | NDA | Current |
| 69344-204 | Zorvolex | diclofenac | Zyla Life Sciences US Inc. | NDA | Current |
| 73480-242 | DICLOFENAC | Diclofenac | TriVue Pharmaceuticals, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80394 | SUPPL | 2024-11-25 |
| 80393 | SUPPL | 2024-11-25 |
| 80313 | SUPPL | 2024-11-22 |
| 67360 | SUPPL | 2021-05-03 |
| 67359 | SUPPL | 2021-05-03 |
| 67285 | SUPPL | 2021-04-30 |
| 52767 | SUPPL | 2018-02-28 |
| 52766 | SUPPL | 2018-02-28 |
| 40397 | SUPPL | 2016-05-11 |
| 19575 | SUPPL | 2016-05-11 |
| 10362 | SUPPL | 2016-05-10 |
| 10361 | SUPPL | 2016-05-10 |
| 32570 | SUPPL | 2014-08-27 |
| 10360 | SUPPL | 2014-08-27 |
| 19574 | SUPPL | 2014-08-26 |
| 19573 | SUPPL | 2014-08-26 |
| 24472 | ORIG | 2014-03-26 |
| 22959 | ORIG | 2014-03-26 |
| 23515 | ORIG | 2013-10-24 |
| 19572 | ORIG | 2013-10-22 |
| 10359 | ORIG | 2013-10-22 |